Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emeline Colomba

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Scientific Reports|November 19, 2025
Molecular profiling of endometrial cancer in Martinique reveals frequent CCNE1 amplification in poor prognosis tumorsTaina Labeau, Jean-Samuel Loger, Mehdi Jean-Laurent, et al.
JCO Oncology Practice|February 23, 2021
Intercontinental Multidisciplinary Oncology Videoconferencing for Rare and Complex Cancer: An Alternative to Systematic TransferCharles Honoré, Olivier Mir, Arthur Geraud, et al.
Cancers|April 12, 2022
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective StudyZoé Guillaume, Emeline Colomba, Jonathan Thouvenin, et al.
European Urology Oncology|December 5, 2025
Germline DNA Repair and Immune-metabolic Alterations Suggest a Potentially Distinct Form of Early-onset Prostate Cancer in Men of African DescentJean-Samuel Loger, Emeline Colomba, Alexis Vallard, et al.
Gynecologic Oncology|December 15, 2022
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinomaEmeline Colomba, Jérôme Alexandre, Gwénaël Le Teuff, et al.
Drugs|May 5, 2022
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate CancerRonan Flippot, Anna Patrikidou, Mihaela Aldea, et al.
Gynecologic Oncology|October 16, 2020
Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registryJudith Michels, Catherine Genestie, Ariane Dunant, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 2, 2024
Copy number signatures and CCNE1 amplification reveal the involvement of replication stress in high-grade endometrial tumors oncogenesisRegine Marlin, Jean-Samuel Loger, Clarisse Joachim, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2026
Cabozantinib in patients with non-locally pretreated brain metastases from renal cell carcinoma: Results of the multicenter phase II trial CABRAMETSylvie Negrier, Loïc Mourey, Cécile Dalban, et al.
Journal of Neurology|February 22, 2023
Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?Cristina Smolenschi, Elie Rassy, Johan Pallud, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Scientific Reports|November 19, 2025
Molecular profiling of endometrial cancer in Martinique reveals frequent CCNE1 amplification in poor prognosis tumorsTaina Labeau, Jean-Samuel Loger, Mehdi Jean-Laurent, et al.
JCO Oncology Practice|February 23, 2021
Intercontinental Multidisciplinary Oncology Videoconferencing for Rare and Complex Cancer: An Alternative to Systematic TransferCharles Honoré, Olivier Mir, Arthur Geraud, et al.
Cancers|April 12, 2022
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective StudyZoé Guillaume, Emeline Colomba, Jonathan Thouvenin, et al.
European Urology Oncology|December 5, 2025
Germline DNA Repair and Immune-metabolic Alterations Suggest a Potentially Distinct Form of Early-onset Prostate Cancer in Men of African DescentJean-Samuel Loger, Emeline Colomba, Alexis Vallard, et al.
Gynecologic Oncology|December 15, 2022
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinomaEmeline Colomba, Jérôme Alexandre, Gwénaël Le Teuff, et al.
Drugs|May 5, 2022
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate CancerRonan Flippot, Anna Patrikidou, Mihaela Aldea, et al.
Gynecologic Oncology|October 16, 2020
Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registryJudith Michels, Catherine Genestie, Ariane Dunant, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 2, 2024
Copy number signatures and CCNE1 amplification reveal the involvement of replication stress in high-grade endometrial tumors oncogenesisRegine Marlin, Jean-Samuel Loger, Clarisse Joachim, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2026
Cabozantinib in patients with non-locally pretreated brain metastases from renal cell carcinoma: Results of the multicenter phase II trial CABRAMETSylvie Negrier, Loïc Mourey, Cécile Dalban, et al.
Journal of Neurology|February 22, 2023
Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?Cristina Smolenschi, Elie Rassy, Johan Pallud, et al.
Pageof 7